S. 3(d): Examiner must identify ‘known substance’, explain how claimed compounds constitute new form
High Court holds Patent Office must identify “known substance” and mention the manner in which claimed compounds constitute new form
Shivarpita Nailwal & Ankita Sabharwal
Sep 19, 2022
Interim Injunction Denied-AstraZeneca AB and Ors. vs. Intas Pharmaceuticals Limited and Ors
About the Parties to the dispute & the subject matter In a recent landmark decision of the Delhi High Court, AstraZeneca AB and...
Saumya Kapoor
Feb 1, 2021
IPAB holds claims of divisional must be derived from claims of parent (not just from specification)
IPAB holds claims of divisional application must be derived from claims of the parent application and not merely from the specification
Shivarpita Nailwal
Oct 31, 2020
